RIBATTI, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 40.431
EU - Europa 7.445
AS - Asia 2.966
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 10
AF - Africa 8
Totale 50.889
Nazione #
US - Stati Uniti d'America 40.405
CN - Cina 2.588
SE - Svezia 2.054
UA - Ucraina 1.395
DE - Germania 1.148
IT - Italia 1.095
FI - Finlandia 747
GB - Regno Unito 468
FR - Francia 162
IE - Irlanda 113
BE - Belgio 102
SG - Singapore 100
IN - India 86
VN - Vietnam 81
RU - Federazione Russa 43
JP - Giappone 29
CZ - Repubblica Ceca 26
NL - Olanda 26
PH - Filippine 26
CA - Canada 24
IR - Iran 17
EU - Europa 12
KR - Corea 9
PL - Polonia 9
AU - Australia 8
AT - Austria 7
BR - Brasile 7
ES - Italia 6
RO - Romania 6
TR - Turchia 6
EG - Egitto 5
MY - Malesia 5
BD - Bangladesh 4
CH - Svizzera 4
CL - Cile 4
IL - Israele 4
RS - Serbia 4
AR - Argentina 3
BG - Bulgaria 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
LU - Lussemburgo 3
PT - Portogallo 3
DK - Danimarca 2
EC - Ecuador 2
GE - Georgia 2
MK - Macedonia 2
MV - Maldive 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
AL - Albania 1
DM - Dominica 1
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
IQ - Iraq 1
KH - Cambogia 1
LI - Liechtenstein 1
LT - Lituania 1
MC - Monaco 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
SA - Arabia Saudita 1
UG - Uganda 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 50.889
Città #
Fairfield 6.228
Woodbridge 4.614
Chandler 3.633
Jacksonville 3.234
Houston 3.094
Ashburn 3.071
Seattle 2.551
Cambridge 2.184
Wilmington 2.035
Ann Arbor 1.764
Nyköping 1.275
Roxbury 817
Lawrence 816
Nanjing 760
Des Moines 514
New York 487
Princeton 409
Bari 392
Beijing 347
Inglewood 262
San Diego 258
Boardman 223
Dearborn 217
Shenyang 196
Hebei 188
Nanchang 188
Jiaxing 151
Grafing 124
Dublin 113
Tianjin 105
Brooklyn 104
Brussels 101
London 99
Changsha 97
Dong Ket 79
Los Angeles 67
Paris 65
Singapore 65
Washington 61
Pune 58
Guangzhou 55
Helsinki 50
Rome 50
Jinan 45
Hefei 44
Redwood City 43
Leawood 42
Auburn Hills 35
Norwalk 33
Mottola 32
Zhengzhou 31
Taranto 30
Milan 29
Wuhan 28
Shanghai 27
San Mateo 25
Ningbo 24
Falls Church 21
Kunming 20
Augusta 18
Brno 18
Taizhou 18
Marseille 17
Munich 17
Osaka 17
Chicago 16
Hounslow 15
Florence 14
Kilburn 14
Fuzhou 13
New Bedfont 13
San Francisco 13
Chiswick 12
Jinhua 12
Padova 12
Prescot 12
Edinburgh 11
Hangzhou 11
Mumbai 11
Quezon City 11
Toronto 11
Amsterdam 10
Indiana 10
Monmouth Junction 10
Ardabil 9
Islington 9
Tappahannock 9
Wuxi 9
Baotou 8
Brescia 7
Modugno 7
Naples 7
Quanzhou 7
Turi 7
Acton 6
Aragona 6
Chongqing 6
Mestre 6
Noicattaro 6
Nürnberg 6
Totale 42.161
Nome #
Significato clinico dell’interleuchina-2 (IL-2) e del suo recettore solubile nelle gammapatie monoclonali e nella crioglobulinemia mista essenziale 358
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 220
Mast cells and angiogenesis in pancreatic ductal adenocarcinoma 183
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 135
Isolation and characterization of neural stem cells from dystrophic mdx mouse 134
Anti-angiogenesis in neuroblastoma 133
Targeting B-cell non Hodgkin lymphoma: New and old tricks 133
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 132
Angiogenesis and antiangiogenesis in triple-negative breast cancer 132
Enhancement of fibroblast proliferation, collagen biosynthesis and production of growth factors as a result of combining sodium hyaluronate and aminoacids 128
Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch 125
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 124
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 124
C-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study C-Kit driven human malignancies 122
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies 119
Angiogenesis in adenosquamous cancer of pancreas 118
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 117
A historical perspective on milestones in multiple myeloma research 116
Altered blood-brain barrier development in dystrophic mdx mice 115
Interval sentinel lymph nodes in melanoma: a digital pathology analysis of Ki67 expression and microvascular density 115
Angiogenesis in Pancreatic Cancer: Pre-Clinical and Clinical Studies 115
Autophagy markers LC3 and p62 accumulate in immune‐mediated necrotizing myopathy 113
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 112
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 111
Broad targeting of angiogenesis for cancer prevention and therapy 110
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 110
Sclerostin stimulates angiogenesis in human endothelial cells 110
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma 110
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma 110
Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue 109
DP71 and SERCA2 alteration in human neurons of a Duchenne muscular dystrophy patient 109
Multiple Myeloma as a model for the role of bone marrow niches in the control of angiogenesis 109
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 109
Targeting angiogenesis in biliary tract cancers: An open option 107
Abnormal distribution of AQP4 in minor salivary glands of primary Sjögren’s syndrome patients 107
Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line 107
Antivascular and antitumor properties of the tubulin-binding chalcone TUB091 107
The chick embryo chorioallantoic membrane as an in vivo experimental model to study human neuroblastoma 107
Marine compounds inhibit growth of multiple myeloma in vitro and in vivo 106
Intussusceptive microvascular growth in tumors 105
A fractal analysis of the spatial distribution of tumoral mast cells in lymph nodes and bone marrow 105
Mast cells positive to tryptase and tumour-associated macrophages correlate with angiogenesis in locally advanced colorectal cancer patients undergone to surgery 105
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation 105
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma 104
Sales for anti-angiogenic drugs 104
Immune cells and angiogenesis 103
The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands 103
A novel RGDS-analog inhibits angiogenesis in vitro and in vivo 102
Tumor refractoriness to anti-VEGF therapy 102
The TGF-β1 signaling pathway as an attractive target in the fibrosis pathogenesis of Sjögren's syndrome 102
Catecholamine release by chromaffin cells: A lesson from mast cells 101
The functional anatomy of the cerebrocerebellar circuit: A review and new concepts 101
A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy 100
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients 100
Erythropoietin in tumor angiogenesis 99
The chick embryo chorioallantoic membrane assay. 98
Lymphangiogenesis in haematological malignancies 97
The discovery of antiangiogenic molecules: a historical review 97
History of research on tumor angiogenesis 97
Endothelial area and microvascular density in a canine non-Hodgkin's lymphoma: an interspecies model of tumor angiogenesis 97
PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma 97
Giulio Bizzozero and the discovery of platelets 96
Recent advances in targeted anti-vasculature therapy: the neuroblastoma model 96
Transgenic mouse models of angiogenesis and lymphangiogenesis 96
A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients 96
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 96
Inulin based micelles loaded with curcumin or celecoxib with effective anti-angiogenic activity 96
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 96
Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma 96
The role of the vascular phase in solid tumor growth: a historical review 95
A new protocol for the treatment of the chronic venous ulcers of the lower limb 95
A portrait of Aristotle as an anatomist: historical article 95
Aquaporin-1 expression in the chick embryo chorioallantoic membrane 94
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 94
Angiogenesis in neuroblastoma 93
null 93
The use of the chick embryo chorioallantoic membrane as experimental model to study virus growth and to test the clonal selection hypothesis. The contribution of Sir Mac Farlane Burnet 93
A brief history of angiogenesis assays 92
Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects 92
Hemilipin, a novel Hemiscorpius lepturus venom heterodimeric phospholipase A2, which inhibits angiogenesis in vitro and in vivo 92
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 92
Angiogenesis during tumor progression in human malignant melanoma 91
The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma 91
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma 91
Angiogenesis and anti-angiogenesis in neuroblastoma 91
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 91
Suggestive evidence of a vesicle-mediated mode of cell degranulation in chromaffin cells. A high-resolution scanning electron microscopy investigation 90
The contribution of Gianni Bonadonna to the history of chemotherapy 90
Inflammation and antiangiogenesis in cancer 90
The Staining of Mast Cells: A Historical Overview 90
Is angiogenesis essential for the progression of hematological malignancies or is it an epiphenomenon ? 89
The chick embryo chorioallantoic membrane as a model to study tumor metastasis 89
Human peripheral blood eosinophils induce angiogenesis 89
Angiogenesis and vasculogenesis in multiple myeloma: role of inflammatory cells 89
Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin 88
Edelman’s view on the discovery of antibodies. 88
An image analysis of the spatial distribution of perivascular mast cells in human melanoma 88
The development of the vascular system: a historical overview. 88
Hydrogels for biomedical applications from glycol chitosan and PEG diglycidyl ether exhibit pro-angiogenic and antibacterial activity 88
Cross talk between natural killer cells and mast cells in tumor angiogenesis 88
Totale 10.772
Categoria #
all - tutte 198.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 198.175


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014.909 2.428 991 491 1.462 1.660 1.010 1.622 1.323 1.851 635 1.077 359
2020/20218.863 810 608 817 531 1.175 463 754 596 863 1.167 547 532
2021/20225.575 297 593 59 237 276 409 321 295 429 534 854 1.271
2022/20238.810 1.385 683 517 924 1.041 1.195 112 916 1.551 91 224 171
2023/20242.956 254 652 179 140 245 831 49 168 15 89 40 294
2024/2025172 172 0 0 0 0 0 0 0 0 0 0 0
Totale 52.108